Approved for To treat locally advanced or metastatic ROS1-positive non-small cell lung cancer. 12.1 Mechanism of Action Taletrectinib is an inhibitor of tyrosine kinase ROS1, including ROS1 resistance mutations. Taletrectinib also showed inhibitory effects on tropomyosin receptor kinases… Side effects, costs, interactions, manufacturer, and generic alternatives sourced from FDA labels, openFDA…
Loading full data from Know Your Drugs Institute…